Mengoni et al. reported that aryl hydrocarbon receptor (AHR), a ligand binding-transcription factor, is enhanced by inflammatory mediators and it increases inflammation-induced dedifferentiation in human and mouse melanoma cells. This evidence concerns the gene AHR and melanoma.